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Abstract 
 
The Ras protein activates at least three different pathways during early development. Two of 
them regulate mesodermal gene expression and the third is thought to participate in the 
control of actin cytoskeleton dynamics via the Ral protein. From a yeast two-hybrid screen of 
a Xenopus maternal cDNA library, we identified the Xenopus orthologue of the Ral 
interacting protein (RLIP, RIP1 or RalBP1), a putative effector of small G protein Ral. 
Previously we observed that a constitutively activated form of Ral GTPase (XralB G23V) 
induced bleaching of the animal hemisphere and disruption of the cortical actin cytoskeleton. 
To demonstrate that RLIP is the effector of RalB in early development, we show that the 
artificial targeting of RLIP to the membrane induces a similar phenotype to that of activated 
RalB. We show that overexpression of the Ral binding domain (RalBD) of XRLIP, which 
binds to the effector site of Ral, acts in competition with the endogenous effector of Ral and 
protects against the destructive effect of XralB G23V on the actin cytoskeleton. In contrast, 
the XRLIP has a synergistic effect on the activated form of XralB, which is dependent on the 
RalBD of RLIP. We provide evidence for the involvement of RLIP by way of its RalBD on 
the dynamics of the actin cytoskeleton and propose that signalling from Ral to RLIP is 
required for gastrulation.  
 
Keywords : RLIP; RalB; FGF pathway;  Xenopus embryo; Actin cytoskeleton; Gastrulation 
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Introduction 
 
The fibroblast growth factor (FGF) family plays an important role in mesodermal induction. 
eFGF (Isaacs et al., 1992), FGF-3 (Tannahill et al., 1992) and FGF-8 (Christen and Slack, 
1997) are expressed at gastrula stages in the marginal zone of Xenopus embryos, where they 
activate the Ras/MAP kinase pathway (Kristen and Grainger, 2000). A dominant negative 
form of FGF expressed in embryos inhibits mesodermal gene expression in animal cap 
experiments and causes gastrulation failure in embryos (Amaya et al., 1991), (Kroll and 
Amaya, 1996) and (Nutt et al., 2001). FGF signalling is also implicated in morphogenesis of 
the mesoderm in Drosophila embryos (Wilson and Leptin, 2000). Through many other 
examples the FGF proteins have also emerged as key mediators of cell migration in vivo. It 
was thus demonstrated that the FGF receptors FGFR8 and FGFR1 are essential for cell 
migration and mesodermal patterning during gastrulation of mouse embryos (Yamaguchi et 
al., 1994). Even though the Ras/MAP kinase pathway is known to be the canonical pathway 
required to transduce the FGF signal, it is now clear that FGF can activate a number of other 
pathways. Indeed, the small G protein Ras activated by the FGF signal, interacts with 
different effectors to direct the signal towards many targets (White et al., 1995). Ras 
signalizing mediates effects such as proliferation, cytoskeleton organization (Bar-Sagi and 
Feramisco, 1986), synergises with MAP kinase to transform cells (White et al., 1996). 
Recently, we demonstrated (Lebreton et al., 2003) that FGF is able to activate the small G 
protein XralB in Xenopus embryos. Ral is a member of the Ras family whose activation can 
be Ras dependent (reviewed in (Feig et al., 1996; Wolthuis and Bos, 1999)), and which is 
found in its active form mainly in the marginal zone of developing Xenopus embryos 
(Lebreton et al., 2003). We previously showed that one target of the FGF/Ras/Ral pathway is 
the cortical actin cytoskeleton that requires no new gene expression, and that overexpression 
of the dominant negative form of XralB in the marginal zone blocks gastrulation movements 
(Moreau et al., 1999). Like Ras, Ral may utilize multiple effectors to mediate its action, and 
some of these effectors may be cell type specific. Proteins such as filamin and 
RalBP1/RLIP76 may be direct effectors of Ral that mediate regulation of either filopodia 
formation (Ohta et al., 1999) or endocytosis (Jullien-Flores et al., 2000), whereas Sec5 
modulates exocyst function as well as filopodia formation (Moskalenko et al., 2002). To 
characterize the Ral pathway and understand its function during early vertebrate development, 
we searched for the RalB effector present during early development. Using a two-hybrid 
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screen, we cloned XRLIP (RIP1 or RalBP1) the putative effector of XralB, and showed that 
targeting of XRLIP to the plasma membrane induces disruption of the actin cytoskeleton 
similar to the effect of the dominant positive form of XralB. We also present evidence from 
rescue experiments that XRLIP is specifically required to induce the phenotype characteristic 
of the activated form of XralB and that, like XralB, XRLIP is necessary for normal 
gastrulation.   
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Results 
 
RLIP is an embryonic target of RalB 
 
Many downstream targets of Ral (RalA or RalB) have been identified in somatic tissues. 
These include phospholipase D (PLD) (Jiang et al., 1995), which interacts with the N-terminal 
sequence of Ral independently of its activation state. Other proteins, namely filamin (Ohta et 
al., 1999), RLIP (Jullien-Flores et al., 1995) (also called RalBP1 (Cantor et al., 1995) (Ikeda 
et al., 1998) or RIP1 (Park and Weinberg, 1995)) and Sec5 (Moskalenko et al., 2002; 
Sugihara et al., 2002) have also been reported to interact specifically with the GTP-bound 
form of Ral. To identify which effector is present during embryonic development, the XralB 
was used as bait in a yeast two-hybrid screen of a Xenopus maternal cDNA library (Iouzalen 
et al., 1998). We isolated from three million clones 23 clones that corresponded to 4 different 
cDNAs coding for proteins that interact specifically with the GTP-RalB form. These proteins 
correspond to the mammalian Ral effector RLIP and have been designated XRLIP for 
Xenopus RLIP. The four XRLIP cDNAs differ in their nucleotide sequence and in the size of 
their 3’untranslated sequence comprised between the stop codon and the poly A tail 
(respectively 182, 263, 289 and 1641 bp for clone 354, 31, 38 and 14). Among the four 
encoded proteins, XRLIP-DH38 (designated XRLIP1) and XRLIP-DH31 (designated 
XRLIP2) share 85% and 81.4% identity with the mammalian RLIP76 sequence. The amino 
acid sequence of the XRLIPs differs from the mammalian sequence by the absence from the 
Xenopus sequence of one repetitive peptide (143EEKHK147) from the amino terminal region in 
the mammalian sequence). The less conserved region, compared to mammalian homologues, 
is located in the 59 carboxy terminal amino acids (Fig. 1). 
The temporal expression of the XRLIP mRNAs was analyzed by Northern blotting of total 
RNAs from different developmental stages and tissues of Xenopus using the coding sequence 
of XRLIP1 as a probe. At least four hybridization signals were detected (Fig. 2A) 
corresponding to four XRLIP transcripts of approximately 5.1 kb, 4.0 kb, 3.2 kb and 2.8 kb. 
The largest transcript (referred to as the adult or tissue-specific form) prevailed in late 
development and in adult tissues, whereas the other transcripts (referred to as developmental 
specific forms), were primarily detected during oogenesis and early development. However, 
an overlapping expression pattern was observed from gastrula to the tadpole stages (a period 
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corresponding to the beginning of organogenesis) and in some adult tissues such as the 
spleen. The presence of 4 different mRNAs as revealed by Northern blot analysis is in 
agreement with the finding of 4 different cDNAs isolated by the two-hybrid screen (Iouzalen 
et al., 1998). This diversity of RLIP mRNAs could originate from genome duplication in 
accordance with the hypothesis of total genome duplication that occurred thirty million years 
ago (Bisbee et al., 1977). 
In the yeast two-hybrid system, all these XRLIP isoforms bound specifically to wild type 
XralB and GTP–bound XralB (XralB G23V) but did not interact with GDP-bound XralB 
(XralB S28NMCT) (Fig. 2C). However, as opposed to previously described results (Bauer et 
al., 1999), the mutants XralB G23VD49N and XralB D49NMCT exhibited the same 
interaction with XRLIP as did XralB G23V.  
The temporal expression of the XRLIP protein was also analyzed by Western blotting using 
antibodies against rat RLIP (RalBP1). The specificity of the rat antibodies against XRLIP had 
previously been tested on XRLIP2 and on a deletion mutant overexpressed in embryos (data 
not presented). As shown in Fig. 2B, two predominant bands of 95 kD and 83 kD were 
detected. These results are in agreement with the size of the RLIP protein observed by Cantor 
et al. (Cantor et al., 1995). The 95 kD band was detected from unfertilized egg to the gastrula 
stages. This expression pattern was comparable to the expression profile of the embryonic 
XRLIP mRNA. Beyond the gastrula stage, however, the pattern changed. The 95 kD band 
disappeared and a smaller one of 83 kD appeared. Analysis of different parts of embryos at 
stage 10.5 of gastrulation revealed the same level of expression of XRLIP protein in the 
whole embryo (data not shown). Taken together, these results show, first, that XRLIP is 
present during the early development of Xenopus without any specific localization, and, 
secondly, that it interacts specifically with either the native or the activated  form of XralB. 
 
In embryos, RLIP interacts with the activated form of Ral. 
 
Using the two-hybrid assay, we showed that RLIP interacts with the activated form of Ral. To 
determine whether this interaction occurs in the embryo, we investigated whether Ral co-
immunoprecipitates with myc-tagged RLIP. Ral protein is known to be associated to the 
plasma membrane. The co-immunoprecipation assay was performed with XralB mutated in 
the CAAX box (XralB C203S), which is ineffective in membrane targetting. As shown in Fig 
3A, XralB G23V interacted with Myc-RLIP (lane 3) whereas XralB G23V injected alone 
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(lane 2) or with Myc-RLIP deleted of its Ral interacting domain (RLIP MRalBD) (lane 4) 
could not be detected by Western blot.  
Since XralB interacts in vivo with RLIP, we postulated that XralB is competent to target RLIP 
to the plasma membrane. To investigate this possibility, the cellular localization of the 
XRLIP2 protein was examined by confocal screening laser microscopy using anti-myc 
antibody. When XRLIP2 mRNA was injected alone, the protein was distributed in the cytosol 
(Fig. 3C left), whereas when XRLIP2 mRNA was coinjected with XralB G23V mRNA, it 
was clearly located in the cortical region of the blastomere  (Fig. 3C middle). We confirmed 
the causal localization of RLIP by RalG23V by coexpression of XralB G23V mRNA and 
XRLIP2 mRNA deleted of its RalB interacting domain (Fig. 3B). In this case, RLIP is 
exclusively located in the cytosol (Fig. 3C right), as when XRLIP mRNA is expressed in the 
absence of Ral. 
Previously, we showed that Ral is activated by FGF. Therefore, we examined whether FGF is 
able to trigger the recruitment of RLIP into the plasma membrane. To this end, we incubated 
in the absence or presence of FGF, animal cap explants from embryos microinjected with 
RLIP2 and Ral wild type mRNAs, and examined the cellular localization of RLIP by confocal 
microscopy. When animal cap explants were incubated in the absence of FGF, Myc-RLIP was 
localized in the cytosol of 72.6% (n=62) of cells examined (Fig 3D); when animal cap 
explants were incubated for 90 min in the presence of 125 ng / ml of FGF, Myc-RLIP was 
located in the periphery in the subcortical area of 88,3% (n=68) of cells examined. In the 
majority of cells originating from animal cap explants incubated with FGF, Myc-RLIP was 
not homogeneously arranged at the periphery of the cell, but preferentially arranged into 
certain characteristic domains. If we compare the localization of Myc-RLIP in animal caps 
incubated in the presence of FGF with the localization of Myc-RLIP targeted to the plasma 
membrane by Ral G23V (Fig 3C middle), the signal was more diffuse near the plasma 
membrane with FGF. Taken together, these results indicate that RLIP interacts with the Ral 
activated form and its localization in the plasma membrane is directed by FGF. 
 
The RalBD of RLIP is necessary for gastrulation 
 
The Ral binding domain (RalBD) of RLIP interacts specifically with Ral and is used to 
measure Ral activation (Wolthuis et al MCB 1998 18, 2486-2491). Previously we showed that 
the overexpression of RalBD in the marginal zone is able to block gastrulation at stage 10.5-
11 (Lebreton et al., 2003) as does a dominant negative form of Ral. Since many effectors of 
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Ral have been characterized, it was necessary to confirm that, in early development, RLIP 
was indeed the Ral effector involved in this phenotype. To investigate this, we examined 
whether the overexpression of RLIP could compete with the RalBD and rescue the wild type 
phenotype. Embryos were injected at the four-cell stage into the marginal zone with RalBD (4 
x 300 pg) or co-injected with XRLIP2 (4 x 1.5 ng) mRNAs. The molar ratio between the 
RalBD and XRLIP mRNAs was 1:1. While an arrest of development at the gastrulation stage 
(stage 10.5) occurred in 87% of the embryos injected with RalBD mRNA, development of co-
injected embryos was delayed compared to uninjected controls (Fig. 4) up to stage 12 (n= 70). 
To examine whether the rescue effect is specific of RLIP, RalBD mRNA was co-injected with 
mRNA coding for RLIP deleted of its RalBD (XRLIPMRalBD). Embryos injected with 4 x 
1.5 ng of XRLIPMRalBD mRNA developed normally (Fig. 4), whereas embryos co-injected 
with RalBD (4 x 300 pg) and XRLIPMRalBD (4 x 1.5 ng) in a 1:1 ratio exhibited the same 
severe defect (Fig. 4) characterized by a blocking of blastopore closure at stage 10.5 (90%; n 
= 45) induced by RalBD. At times, failure of gastrulation of embryos injected with RalBD 
alone or with  XRLIPMRalBD (40-50%) was accompanied by a leakage of vitellus around the 
blastopore lip. This effect, observed in only 10% of the embryos co-injected with XRLIP 
(data not shown), could be related to membrane fragility of the mesendodermal cell due to 
inhibition of the RalB pathway. These data clearly show that the RalBD, like the dominant 
negative form of Ral, inhibits the gastrulation process, and that, by a specific rescue with 
XRLIP but not with XRLIPMRalBD, this effect is dependent on the RalBD. 
 
RLIP, the putative RalB effector, is necessary for the RalB pathway to act on the actin 
cytoskeleton 
 
The depigmented phenotype observed in XralB G23V injected embryos has been correlated 
with F-actin disruption (Moreau et al., 1999). We sought to determine whether RLIP is 
involved in actin disruption and whether there is a functional link between Ral and the actin 
cytoskeleton. To test this hypothesis, we examined whether RalBD can compete, as in 
gastrulation, with endogenous RLIP to interfere in the depigmentation phenotype induced by 
the constitutively activated form of XralB G23V. Embryos were injected with XralB G23V 
RNA (300 pg) alone or together with GST-RalBD RNA (5 ng). This corresponds to a 1:2 
ratio of XralB G23V mRNA : GST-RalBD mRNA. In these conditions, XralB G23V alone 
induced depigmentation in 92.6% of the embryos at the blastula stage. Later, the animal 
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hemisphere of the injected embryos developed ectodermal lesions, and the embryos did not 
survive beyond the blastula stage. When the GST-RalBD and XralB G23V mRNAs were co-
injected, the depigmented phenotype was significantly reduced (Fig. 5A) and survival of 
embryos was dramatically improved, since only 9.8% of the embryos presented extensive 
ectodermal lesions and died before gastrulation, whereas 20.3% reached stage 32 (Table 1). 
Nevertheless, all surviving embryos exhibited gastrulation abnormalities including an open 
blastopore and a shortened antero-posterior body axis. These phenotypes relate to RalBD 
overexpression. To check if the rescue effect could be correlated with expression of GST-
RalBD, proteins synthesized from the injected mRNAs were monitored by Western blot. The 
amount of XralB protein produced was comparable (data not shown) whether XralB G23V 
mRNA was injected alone or with RalBD and confirmed that the rescue effect of XralB G23V 
can be attributed to the presence of the GST-RalBD protein. This rescue effect was also 
analyzed by observing the actin cytoskeleton by confocal microscopy. When XralB G23V 
mRNA was co-injected with GST-RalBD mRNA, the cortical actin cytoskeleton was partially 
present, whereas it was absent from embryos injected with XralB G23V mRNA alone (Fig. 
5B). To show that rescue of XralB G23V by expression of RalBD was not due to competitive 
association of the RalB catalytic domain with another effector, XralB G23V was co-injected 
with XRLIP2 mRNA (Fig. 6A). Coexpression did not diminish the depigmentation induced 
by XralB G23V, but enhanced it. When XralB G23V mRNA was co-injected with mRNA 
coding for the Green Fluorescent Protein (GFP from the GFP.RN3 plasmid kindly provided 
by Dr J.B. Gurdon), no significant alteration of depigmentation, either positive or negative, 
was observed. To confirm the enhancer effect of XRLIP2 expression, XralB G23V mRNA 
was injected at a lower concentration (100 pg /blastomere) that did not induce depigmentation 
in early embryos, or was co-injected with either  the XRLIP2 (3 ng) or GFP (2 ng) mRNAs. 
Co-injection of all embryos with the XralB G23V and XRLIP2 mRNAs (n=40) led to 
depigmentation starting from the 64-cell stage (Fig. 6A), whereas embryos injected with 
XralB G23V mRNA alone or together with GFP mRNA (2 ng) developed normally, without 
any alteration of pigmentation.  
These results clearly show an enhancing effect of XRLIP2 on the XralB activated form. To 
confirm that this synergistic effect was due to interaction of the RalBD of XRLIP2 with 
XralB, we examined whether overexpression of XRLIP2 deleted of its Ral binding domain 
(XRLIP2 MRalBD) also affected XralB G23V-induced depigmentation. XRLIP2 MRalBD 
mRNA (3 ng) was injected alone or with XralB G23V mRNA (100 pg) into both animal 
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blastomeres at the 2-cell stage. Whether these two mRNAs were injected individually or 
jointly, no depigmentation was observed (Fig. 6B).  
Consequently, these data show that the RalBD of XRLIP2 is involved in the interaction with 
XralB in vivo, that XralB directs RLIP to the plasma membrane and that XRLIP2 is most 
likely required for the Ral pathway to act on pigmentation distribution.  
 
Docking of RLIP to the membrane induces actin disruption 
 
Since expression of the constitutively active XralB mutant requires XRLIP2 to induce 
depigmentation, we next examined whether the Ral protein acts by recruiting XRLIP2 to the 
membrane and disturbs the actin cytoskeleton. Previously, it was demonstrated that the 
carboxy terminal CAAX sequence of Ras is sufficient to promote localization of Raf to the 
membrane (Mineo et al., 1997), and that expression of the RalGEF Rlf-CAAX or of Raf1-
CAAX (Verheijen et al., 1999) is sufficient to induce differentiation of F9 embryonal 
carcinoma cells. Therefore, the 10 C-terminal amino acids of XralB were fused to the C-
terminal end of XRLIP2 to determine if localization of RLIP to the membrane can mimic the 
XralB G23V effect. Embryos were injected with 1.5 ng of XRLIP2-CAAX mRNA into the 
two animal blastomeres at the 2-cell stage. Depigmentation of the animal blastomeres in all 
embryos (n= 110) was observed from the 32-cell stage onwards (Fig. 7A). However, unlike 
the effect of the activated form of XralB, XRLIP2-CAAX induced a rounded appearance of 
the blastomeres during the cleavage stage, which could correspond to loss of adhesion. 
Moreover, whereas the external surface of depigmented blastomeres injected with XRalB 
G23V was smooth, XRLIP2-CAAX-injected blastomeres were irregular with dynamic 
membrane ruffling and finger-like protrusions that changed extremely rapidly (Fig. 7D). 
Although these phenotypes were more dramatic than the phenotype induced by the expression 
of XralB G23V, later in development the blastomeres of embryos injected with XRLIP2-
CAAX mRNA seemed to revert to normal, and the embryos survived beyond the gastrula 
stage. To determine whether XRLIP2-CAAX was present in the plasma membrane, the 
cellular localization of the protein was examined by confocal screening laser microscopy 
using anti-myc antibody. In contrast to XRLIP2, which was mainly detected inside the cytosol 
and only faintly on the plasma membrane, XRLIP2-CAAX was clearly located in the cortical 
region of the blastomere (Fig. 7B). As the depigmentation of blastomeres expressing XralB 
G23V is always associated with alteration of the cortical actin cytoskeleton, we investigated 
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whether XRLIP-CAAX also affects the integrity of the actin cytoskeleton. Figure 7C shows 
the confocal analysis of the cortical actin cytoskeleton of animal blastomeres from uninjected 
embryos and from embryos injected with XRLIP2, XRLIP2-CAAX or XralB G23V mRNA. 
Only the embryos injected with either the XRLIP-CAAX or the XralB G23V mRNA 
exhibited severe disruption of the cortical actin cytoskeleton.  
These results demonstrate clearly that XRLIP partly phenocopies the XralB G23V 
effect when the protein is translocated to the plasma membrane. Taken together, these data 
suggest that RLIP is recruited to the plasma membrane through its interaction with XralB to 
affect the integrity of the actin cytoskeleton. However, the different appearance of 
blastomeres induced by overexpression of XralB G23V or XRLIP-CAAX and the relative 
reversibility of the depigmented phenotype induced by XRLIP compared with the stable 
phenotype induced by XralB G23V, suggest that another Ral effector could be present in 
embryos and could cooperate with RLIP. 
 
Docking of RLIP to the membrane is required to transduce the Ral signal during 
gastrulation  
 
We showed previously that both the RalBD of RLIP and the dominant negative form 
of Ral (XralB S28N) blocked gastrulation movements when specifically injected into the 
marginal zone of embryos (Lebreton, 2002) and (Lebreton et al., 2003), but have no effect 
when injected into the animal or vegetative pole. However, it cannot be excluded that another 
effector, not identified by the two-hybrid screen, interacts with XralB in Xenopus embryos. 
The overexpression of myc- or GST-RalBD could therefore compete with such an effector for 
binding with the effector domain of XralB. To clarify this point, XRLIP2 was overexpressed 
in embryos to saturate the effector site of endogenous Xral, and thereby suppress the potential 
recruitment of another putative effector. Injection of 1 ng XRLIP mRNA into the marginal 
zone of each blastomere at the 4-cell stage did not alter the development of the embryos, and 
more than 90% (n=42) reached the tailbud stage without exhibiting any abnormal phenotype. 
This result favours the hypothesis that the effect of RalBD is specific of the endogenous 
XRLIP protein and is not due to possible competition with another effector. 
Since activated forms of XralB and XRLIP produce similar effects on cortical actin 
integrity in blastomeres of the animal hemisphere, and since XRLIP did not compete with 
another putative Ral effector, we sought to confirm that RLIP is a part of the RalB pathway in 
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the morphogenetic events affecting the marginal zone mesoderm during gastrulation. Hence, 
we tested whether the inhibitory effect of XralB S28N on gastrulation could be rescued by co-
injection with RNA encoding XRLIP2-CAAX. To this end, the amount of XRLIP2-CAAX 
mRNA that did not induce depigmentation of the embryo or have deleterious effects on early 
development was determined. Based on the observation that 500 pg of XRLIP2-CAAX 
altered neither pigmentation nor gastrulation, 750 pg of XralB S28N mRNA alone or together 
with either XRLIP2-CAAX mRNA (500 pg) or -galactosidase mRNA (500 pg) as control 
were microinjected into the marginal zone of embryos. Whereas XralB S28N mRNA alone or 
co-injected with -galactosidase mRNA blocked gastrulation of 90% of the embryos between 
stage 10.5 and 11 (Fig. 8A), co-injection of XralB S28N with XRLIP2-CAAX allowed all the 
embryos (n= 35) to develop to the end of gastrulation (stage 12; Fig. 8A). Compared with 
uninjected siblings, co-injected embryos presented a delay in development, yet 50% of the 
embryos (n = 42) closed their blastopore completely and 15% developed up to the early 
tailbud stage (stage 21). Protein expression in embryos injected with the XralB S28N and 
XRLIP2-CAAX mRNAs was monitored by Western blot (Fig. 8B) and the expression of the 
dominant negative form of XralB in rescued embryos was confirmed. Thus, XRLIP-CAAX 
rescues inhibition of gastrulation caused by overexpression of XralB S28N and partly extends 
normal development of the embryos compared to siblings injected with XralB S28N alone. 
Hence 500 pg of XRLIP2-CAAX mRNA was sufficient to rescue Xral S28N. These results 
indicate that XRLIP is required for the gastrulation process and that it functions in the Ral 
pathway in vivo.
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Discussion 
 
RLIP is the downstream effector of RalB 
 
I is known that signalling pathways do not correspond to a simple linear signalling 
cascade but include many branchings that crosstalk with other signalling pathways in order to 
direct signals towards multiple targets or to initiate self-assembly of active multiprotein 
complexes. The Ras protein activated by FGF signalling interacts with at least three effectors. 
Each effector has different targets that control processes such as gene expression and actin 
cytoskeleton dynamics (reviewed in (Vojtek and Der, 1998) and (Reuther and Der, 2000)). 
Thus, the FGF signal transduction pathway exemplifies the nature of complex biological 
responses. It is clear today, that during embryonic development, FGFs play an essential role 
in both the morphogenesis and patterning of mesoderm, in particular during gastrulation. 
During gastrulation in Xenopus, FGFs are expressed in the marginal zone whereby they 
activate MAP kinases and are concordant with Xbra expression. The aim of the present study 
was to characterize the Ral pathway and its involvement in the molecular mechanisms of 
early vertebrate development. To date, several target molecules of Ral have been identified. 
All previous data concerning the identification of Ral-binding proteins were derived from 
experiments carried out in adult mammalian tissues or cell cultures. Therefore, we 
investigated which effector could be identified in early embryonic development. Using a two-
hybrid screen of a maternal Xenopus library, we isolated cDNAs encoding proteins that 
specifically interact with Ral-GTP. These proteins correspond to at least two orthologues of 
mammalian RLIP, one preferentially expressed in adult tissues (XRLIP1) and the second 
preferentially expressed during embryonic development (XRLIP2). For the first time, the 
interaction of RLIP with Ral is demonstrated in vivo by the co-imunoprecipitation of Xral 
with XRLIP2. Thus we suggest that RLIP is the effector protein of Ral. We previously 
demonstrated, by animal cap explant experiments, that FGF activates Ral (Lebreton et al., 
2003). Our current study shows that cytosolic RLIP is relocated to the cortical area in a FGF-
dependent manner. Indeed, overexpression of the RalBD of XRLIP in the marginal zone of 
the embryo blocked gastrulation as does the constitutively inactivated form of XralB. Both 
mRNAs arrest gastrulation between stage 10.5 and 11 in a dose-dependent manner. In 
contrast, overexpression of XRLIP2 in the same region does not alter gastrulation. The 
overexpression of XRLIP2 has a synergistic effect on the activity of XralB G23V on cortical 
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actin. This synergistic effect of XRLIP requires its RalBD. Moreover targeting of XRLIP to 
the plasma membrane through a XralB CAAX sequence phenocopies the effect of XralB 
G23V on pigmentation and actin cytoskeleton integrity. The putative Ral effector function of 
RLIP was reinforced by the rescue experiment in which XRLIP2-CAAX was able to revert 
the arrest of gastrulation induced by XralB S28N. As no enzymatic activity can be associated 
with the activation of XRLIP by RalB, it is likely that GTP-bound Ral acts on RLIP by its 
recruitment  to the plasma membrane where it in turn recruits other proteins. So far, four 
protein domains involved in different functions have been identified in RLIP. The N-terminal 
O2 binding domain (Jullien-Flores et al., 2000) and potentially also the C-terminal Reps1 
binding domain (Nakashima et al., 1999) are involved in endocytosis. A third domain that 
joins the C-terminal Reps1 binding domain, interacts with the GTP-bound Ral protein, and a 
fourth domain, between  the O2 domain and the RalBD contains a GTPase-activating protein 
activity (GAP) that acts on the Rac and Cdc42 proteins (Cantor et al., 1995) (Jullien-Flores et 
al., 1995) (Park and Weinberg, 1995). Rac and Cdc42 are members of the Rho family of 
GTPases. These proteins regulate diverse cellular processes and in turn control reorganization 
the actin cytoskeleton (Ridley et al., 1992), (Kozma et al., 1995). This suggests that Ral can 
participate in the control of polymerisation-depolymerisation of actin filaments by activation 
or inactivation of the Rac and Cdc42 activity through the RLIP GAP activity. During early 
Xenopus development, overexpression of a dominant negative Cdc42 inhibits convergent 
extension (Djiane et al., 2000), while Rac inhibits gastrulation (unpublished results), and Rho 
(Wunnenberg-Stapleton et al., 1999) like Rac is important for cell-cell adhesion. These three 
closely related proteins, Rho, Rac1 and Cdc42, are indispensable for fibroblast and epithelial 
cell motility, due to their ability to regulate actin cytoskeletal dynamics, such as filopodia and 
lamellipodia extensions (Hall, 1994), (Zigmond, 1996). Consequently, the GAP activity of 
RLIP could be a possible candidate involved in depigmentation induced by targeting RLIP to 
the plasma membrane. Today, few examples exist in which the Ras-Ral pathway is involved 
in cell migration as in chemotactic migration of myoblasts (Suzuki et al., 2000) or in 
activation of invasiveness of fibroblasts (Ward et al., 2001).  
While our data suggest that Ral and RLIP are involved in the control of actin rearrangement, 
other studies (Nakashima et al., 1999) (Matsuzaki et al., 2002) (Moskalenko et al., 2002) 
suggest a role for these two proteins in endocytosis and exocytosis. These two mechanisms 
are coordinated and could be necessary for cell migration (Lauffenburger and Horwitz, 1996). 
For example they may signal to recycle integrin by endocytosis in the trailing edge region of 
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cell, to promote detachment from the substrate, and to create new adhesions at the leading 
edge (Bretscher, 1992) .  
Finally, it has been shown that during gastrulation FGF is required for cell convergent 
extension movements by inducing mesodermal genes such as brachyury, which in turn 
activates targets such as Wnt11 (Tada and Smith, 2000). Previously (Lebreton et al., 2003) we 
demonstrated that FGF controls morphogenetic movements of gastrulation by a different 
pathway than MAP Kinase and gene activation. Here, our studies show that RalB activated by 
FGF recruites RLIP to the plasma membrane and locally regulates the dynamics of the actin 
cytoskeleton to allow gastrulation. These results make it possible to establish a parallel 
between the function of the RLIP protein on one hand, and one the other hand the 
involvement of the dishevelled protein in the non-canonical Wnt/Fz/Dvl/Daam1/Rho and 
Wnt/Fz/Dvl/Rac pathway (Habas et al., 2003). In both cases, Wnt and FGF, through 
dishevelled and RLIP respectively, locally regulate the small G protein family 
Rho/Rac/Cdc42 to control actin cytoskeletal dynamics and thus morphogenetic movements. 
The next challenge will be to investigate whether the GAP domain of RLIP is required for 
actin cytoskeleton dynamics and gastrulation, and to define the cellular behaviour dependent 
on the Ral/RLIP pathway. 
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Experimental Procedures 
 
Two-hybrid Screen and Two-hybrid Assays 
Screening of the library and controlling the binding of XRLIP sequences selected from the 
Xenopus library with Ral mutants have been described (Iouzalen et al., 1998). 
 
Northern Blot 
 Isolation of RNA from embryos, electrophoresis and hybridization were carried out as 
described (Iouzalen et al., 1998). 
 
Embryos and Microinjections 
Xenopus laevis were imported from South Africa (South Africa Farms, Fish Hoek) or from 
the CNRS frog colony (Rennes). Animals were housed and fed as described (Gurdon et al.  
1984). Embryos were fertilized in vitro and chemically dejellied with 0.3 X modified Barth’s 
solution pH 7.6 (MBS) with 2% cysteine-HCl, pH 7.8-7.9, and then maintained in 1 X MBS 
(Gurdon and Wickens, 1983) until used. Microinjection was performed in 1 X MBS with 3% 
Ficoll, followed by incubation of the embryos overnight at 16° C in 0.1 X MBS with 3% 
Ficoll, and then at 15-22°C until they reached the appropriate stages. Embryonic stages were 
determined according to Nieuwkoop and Faber (Nieuwkoop and Faber, 1956). In vitro 
transcribed mRNAs (4.6 nl of the appropriate dilutions) were microinjected into the animal 
hemisphere of 2-cell stage embryos, or into the marginal zone of 4-cell stage embryos. 
 
Western Blots and binding assay of RLIP and XralB 
Proteins were extracted by lysing embryos in 20 Ol of buffer A (50 mM Tris-HCl pH 7.5, 100 
mM NaCl, 0.1% Triton X-100, 5 mM EDTA, 2 mM PMSF) per embryo, followed by Freon 
extraction of the vitellus. Protein extracts were separated by SDS-PAGE on a 7.5% 
acrylamide gel and transferred to a Hybond C membrane (Amersham). The membrane was 
probed overnight at 4°C with goat anti-human RLIP antibodies (Sc-1948, Santa Cruz) diluted 
1/250 in 1 X PBS, 0.1% Tween 20 and 10% milk. The second antibodies were peroxidase – 
coupled rabbit antibodies specific to goat immunoglobulins and diluted 1/2500 (Chemicon). 
The signals were detected by chemiluminescence (ECL, Amersham). 
Translation of myc-RalBD and myc-XRLIP2-CAAX after microinjection of the mRNAs was 
checked by probing the membrane with a monoclonal  antibody directed against the myc 
epitope (9E10, Santa-Cruz, Sc-40) at a dilution of 1/1000 in 1 X PBS, 0.1% Tween  20 and 
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5% BSA.  Antibodies against -tubulin (N357, Amersham) were used at a dilution of 1/4000 
in 1 X PBS, 0.1% Tween 20 and 5% BSA to monitor the amount of proteins loaded on the 
gels. 
To show the interaction of RLIP with Ral, embryos expressing Myc-RLIP (full lengh or 
deleted of Ral binding domain) were suspended in lysis buffer (Tris 50 mM pH 7.5, NaCl 100 
mM, Triton X100 0.5% and 1 mM PMSF). The lysate was centrifugated  at 10000 rpm for 30 
min and supernatant was  mixed twice with  1,1,2-trichlorofluoroethan and aqueous phase 
incubated  over night with 6 Ol of Myc (9E10) antibody bound to agarose (Santa-Cruz, Sc-40-
AC).  
 
cDNA cloning and in vitro transcription of RNA for injection 
pRN3-myc-XRLIP2 was constructed by inserting the EcoRI fragment of the pGAD-XRLIP-
DH31 selected from the two-hybrid screen (Iouzalen et al., 1998) into the EcoRI site of the 
pRN3-myc vector. To obtain pRN3-XRLIP2-CAAX, the membrane-targeting CAAX signal 
of XralB was added to the 3’ end of the XRLIP2 coding sequence by PCR using pRN3-myc-
XRLIP2 as template, the primer (5’–AACCGTGTCCTGTATGTG-3’) matching a sequence 
upstream of an internal Sac I restriction site in the XRLIP2 coding sequence, and the reverse 
primer (5‘–
CGAGTTAGCGGCCGCTCAGAGTAAACAGCAGCGTTGTTTGAAGCCCTTGATGAGA
GTTTCAGAGG- 3’) containing the CAAX sequence and a Not I restriction site (Not I site 
underlined). The amplified fragment coding for XRLIP2-CAAX was digested with SacI and 
NotI and exchanged with the SacI-NotI fragment of XRLIP2 in pRN3-myc-XRLIP2. 
pRN3-XRLIP2-MRalBD was constructed by PCR amplification of the sequence coding for 
the N-terminal region of the protein starting at amino acid 473, using RLIP as template. The 
primer (5’-GCGGAACAGGAGCTCCTTGTGGCAATGGAGCAG-3’), introducing a Sac I 
restriction site (double underline), was used with the reverse primer (5’-
GGAGCAGATACGAATGGCTAC-3’) located within the pRN3 vector downstream of the 3’ 
Not I integration site. The Sac I-Not I fragment of XRLIP2 was then exchanged with the Sac 
I-Not I digested fragment of the PCR amplification product, thereby deleting the region 
delimited by amino acids 343 and 473, that corresponds to the entire RalBD. 
RNA transcripts were produced using T3 RNA polymerase. Capped mRNAs were obtained 
with the mMessage Machine System (Ambion) according to the manufacturer’s instructions. 
 
17 of 27
Tuesday , July  13, 2004
Elsevier
Re
vie
w 
Co
py
18
 
Immunostaining of Embryos and Confocal Microscopy Analysis  
 
Xenopus embryos at the appropriate stage of development were incubated in a 
permeabilization buffer (80 mM Hepes pH 6.8, 1 mM MgCl2, 100 mM EDTA, 30 % glycerol, 
0.1 % Triton X-100) for 15 min at room temperature before being fixed in 1 X PBS and 1.4% 
formaldehyde overnight, or their vitelline membrane was manually removed under a 
binocular microscope before being fixed in 1 X PBS and 3.5% formaldehyde  for 1 hour at 
room temperature. Embryos were then treated as described (Moreau et al., 1999). The 9E10 
anti-myc antibody was diluted 1/1000 in 1 X PBS, 1% BSA and 0.1% Triton X-100. Confocal 
observations were made as described (Moreau et al., 1999), using a Leica SB2 AOBS 
confocal imaging system (Leica Instruments, Heidelberg, Germany). 
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Table I - Arrest of development caused by 
constitutively activated RalB (XralB G23V) and 
rescued by the RalBD mRNA. 
 
RNA injected 
No of 
embryos 
% ectodermal 
lesion at 
blastula stage 
% alive 
 at  stage 
32 
G23V 135 92.6 3.1 
G23V / RalBD 133 9.8 20.3 
G23V / RLIP 32 96.0 4 
G23V / GFP 75 95.5 0 
RLIP 71 0 100 
Note. Each blastomere of two-cell embryos was 
injected with the amount of mRNA indicated in the 
legend of Fig. 4. The data of at least three separate 
experiments were pooled. 
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Figure legends 
 
Figure 1 
Amino acid sequence alignments between human RLIP (Q15311) and Xenopus XRLIP1 
(AJ252165) and XRLIP2 (AJ304845) proteins. Dashes represent gaps inserted to maximize 
alignment. 
 
Figure 2 
A - Temporal expression of Xenopus XRLIP mRNAs during oogenesis, development and in 
some adult tissues analyzed by Northern blot. Ten Og of RNA of each stage were loaded, 
except for oogenesis stage I/II where 2 Og were loaded. RNAs were separated on an agarose 
gel, blotted and hybridized with the XRLIP DH14 probe. EF1- [Krieg, 1989 #94] was used 
as loading control on the same Northern blots (the zygotic transcription of EF1- mRNA 
begins at the mid-blastula transition (MBT). B – Temporal expression of the Xenopus XRLIP 
proteins during development. Protein extracts corresponding to one embryo for each of the 
different developmental stages were run on an SDS-polyacrylamide gel and immunoblotted 
with antiserum against RLIP. Protein loading on each lane was monitored with anti-tubulin 
antibodies (Ab tubulin).  C - XRLIP interacts specifically with RalB in the two-hybrid system. 
Interactions of both Xenopus XRLIP, XRLIP DH31 (amino acids 19 to 655) and XRLIP 
DH14 (amino acids 30 to 655), were tested with either the inactivated form (XralB 
S28NMCT), both activated forms, (XralB G23V, XralB G23VD49N), or wild type XralB. 
Human lamin served as control.  
 
Figure 3 
In vivo interaction of Ral with RLIP. Embryos at the two cell stage were microinjected  with 
XralS28NC203S (lane2) mRNA or co-injected with Myc-XRLIP2 (lane 3) or Myc-
XRLIP2MRalBD (lane 4) proteins were extracted at stage 10.5. Myc-XRLIP and Myc-
XRLIP2MRalBD were immuno retained on agarose and the co-immuno retained Ral proteins 
were assessed with anti-RalB antibodies. Panel A shows the RLIP retained by anti–Myc 
agarose and displays the associated RalB (IP:RalB). B - Schematic representation of XRLIP2 
indicates the position of the RalBD in XRLIP2 and the deletion of this domain in 
XRLIP2MRalBD. Numbers refer to amino acids. C - Localization of XRLIP was visualized 
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with the monoclonal c-myc antibody 9E10 and secondary antibodies conjugated to FITC. D – 
Localization of XRLIP in cells of animal cap incubated with FGF. Scale bars represent 50 
Om, each picture corresponds to the stacking of 3 confocal optical sections of 1 Om thickness.  
 
Figure 4 
Rescue of RalBD-injected embryos is dependent on the RalBD of RLIP. All embryos 
correspond to the same developmental stage (stage 12.5) as the sibling controls (top row, left). 
Each blastomere of four-cell-stage embryos was injected in the marginal zone. Embryos 
injected with RLIP (middle left) or RLIP2MRalBD (bottom left) mRNAs developed normally 
with a short delay in development compared with controls. RalBD mRNA injection (400 pg) 
arrested development at stage 10.5 (top right). RLIP mRNA rescued the effect of RalBD 
mRNA (middle right). However, when RalBD mRNA was co-injected with XRLIP2MRalBD 
mRNA (bottom right), embryos were blocked at the beginning of gastrulation (stage 10.5) as 
were embryos injected with only RalBD mRNA (top right). 
 
Figure 5 
RLIP acts on the actin cytoskeleton by its RalBD. A - View of the animal hemisphere of 
embryos at the large-cell blastula stage. Embryos were injected into each blastomere at the 2-
cell stage with 300 pg of XralB G23V mRNA (G23V), or 5 ng of GST-RalBD mRNA, or co-
injected with 300 pg of XralB G23VmRNA and 5 ng of GST-RalBD mRNA. B - Rescue of 
the effect of XralB G23V mRNA on cortical actin cytoskeleton by co-injection with GST-
RalBD mRNA. Analysis by confocal scanning microscopy of actin cables stained by 
rhodamine-phalloidin (7.5 Og/ml). Embryos injected in each blastomere with 300 pg XralB 
G23V mRNA, or co-injected with 5 ng of GST-RalBD mRNA, cultured until the midblastula 
stage. Arrows show the partially reconstituted cortical actin cables. Scale bars represent 50 
Om, confocal optical sections are 1 Om thick.  
 
Figure 6 
Synergistic effect of XRLIP2 and RalG23V. A - Embryos were injected in the animal 
hemisphere with XralB G23V mRNA (300 pg) alone, or co-injected with 3 ng of either 
XRLIP2 or GFP mRNAs. B – XRLIP2, but not XRLIP2MRalBD enhances the XralB G23V 
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effect. Embryos were injected with 100 pg of XralB G23V mRNA, 3 ng XRLIP2 mRNA, or 3 
ng of XRLIP2MRalBD mRNA, or co-injected with XralB G23V and XRLIP2 or 
XRLIP2MRalBD mRNAs. Depigmentation was observed only when XralB G23V mRNA was 
co-injected with XRLIP.  
 
Figure 7 
XRLIP2-CAAX phenocopies the XralB G23V effect. A – Three nanograms of XRLIP2 
CAAX mRNA, XRLIP mRNA, or 500 pg of XralB G23V mRNA were injected into the 
animal hemisphere of 2-cell stage embryos. Only XRLIP2-CAAX and XralB G23V induced 
depigmentation of the embryos. B - Targeting of XRLIP2 to the plasma membrane.  All 
XRLIP constructs contain a c-myc tag at the N terminus. XRLIP2 or XRLIP2-CAAX (1 ng 
each) mRNA were microinjected into embryos at the 2-cell stage. Localization of XRLIP was 
visualized with the monoclonal c-myc antibody 9E10 and secondary antibodies conjugated to 
FITC. C – Confocal microscope analysis of actin cytoskeleton cables stained by rhodamine-
phalloidin at the 500 cell stage in animal pole explants. The cortical actin cytoskeleton is 
visible only in uninjected control embryos and embryos injected with wild type XRLIP. Each 
picture corresponds to stacking of 3 confocal optical sections of 1 Om thickness. D - 
Magnification of animal blastomeres in an embryo injected with 0.75 ng of XRLIP2-CAAX 
mRNA shows dynamic finger-like protusions on the cell surface (black arrowheads). Cell 
division proceeds normally (white arrowheads). The time lapse between each picture is 15 
mn. Scale bars represent 50 Om. 
 
Figure 8  
Rescue of the Xral S28N induces gastrulation defect by XRLIP2-CAAX expression. A - 
Embryos at the 4-cell stage were microinjected in the marginal zone with 750 pg/blastomere 
of XralB S28N mRNA or 500 pg/blastomere of XRLIP2-CAAX mRNA, or coinjected with 
both mRNAs. The figure shows a vegetal view of embryos at the same developmental time 
after fertilization, as control siblings. Only embryos in which XralB S28N mRNA has been 
injected alone exhibit a very wide blastopore compared to control uninjected embryos. 
Embryos co-injected with XralB S28N and RLIP2-CAAX mRNAs are delayed in blastopore 
closure. B - Analysis by Western blot of protein expression in rescue experiments using 
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appropriate antibodies (anti-RalB, and anti-myc for the XRLIP constructs). Each lane was 
loaded with protein extracts corresponding to 1 embryo. 
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